← All Pliant Therapeutics, INC filings

Pliant Therapeutics, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
PLRX
Pliant Therapeutics, INC
DEF: Pliant Therapeutics 2026 Annual Meeting Proxy Statement
Pliant Therapeutics has issued its 2026 proxy statement detailing director elections, executive compensation, and the ratification of its independent auditor.
NASDAQ
PLRX
Pliant Therapeutics, INC
DEFA14A: Pliant Therapeutics Sets Date for 2025 Annual Meeting, Outlines Key Proposals
Pliant Therapeutics announces its 2025 Annual Meeting of Stockholders to be held virtually on June 5, 2025, with voting open until June 4, 2025.
NASDAQ
PLRX
Pliant Therapeutics, INC
DEF: Pliant Therapeutics Announces 2025 Annual Meeting and Officer Exculpation Proposal
Pliant Therapeutics sets date for its 2025 Annual Meeting of Stockholders and proposes an amendment to its charter to limit officer liability.
NASDAQ
PLRX
Pliant Therapeutics, INC
DEFA14A: Pliant Therapeutics Files Definitive Proxy Statement with SEC
Pliant Therapeutics has filed a definitive proxy statement with the Securities and Exchange Commission (SEC) regarding its upcoming shareholder meeting.
NASDAQ
PLRX
Pliant Therapeutics, INC
DEF 14A: Pliant Therapeutics Sets Date for 2024 Annual Stockholders Meeting, Outlines Key Proposals
Pliant Therapeutics announces its 2024 Annual Meeting of Stockholders to be held virtually on June 13, 2024, featuring proposals for director elections, executive compensation approval, and accounting firm ratification.